HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders.

Abstract
In adult muscle, acetylcholine receptors (AChR) are restricted mainly to the motor endplate where the adult isoform (alphabetadeltaepsilon) is expressed. When skeletal muscle is denervated in animal models, there is atrophy of the muscle and a marked increase in expression of the AChR foetal isoform (alphabetagammadelta) containing a gamma-subunit. Similar changes in AChR expression are thought to occur in human muscle. While the role of denervation in regulating AChR gene expression has been widely studied, it has not been determined whether the transcriptional programmes responsible for defining different fibre types have an impact on the expression of AChR genes. We investigated biopsies from patients with a wide spectrum of neuromuscular diseases for expression of the AChR alpha- and gamma-subunits using RNase protection assays, alpha/gamma-duplex reverse transcriptase polymerase chain reaction, immunohistochemistry for foetal AChR and RNA in situ hybridization. Muscle from all patients with neurogenic disorders and, to a lesser extent, myogenic disorders, exhibited markedly increased transcription of the AChR gamma-subunit but, in contrast to previous animal studies, did not show increased AChR alpha-subunit. Moreover, both immunohistochemistry and RNA in situ hybridization revealed that AChR gamma-subunit hyperexpression occurred exclusively in atrophic type 1 and not in atrophic type 2 muscle fibres, irrespective of the underlying neuromuscular disease. We conclude that up-regulation of the AChR gamma-subunit in human muscle disorders is restricted to type 1 muscle fibres and, therefore, that AChR gamma-subunit expression is controlled by a muscle fibre type-restricted transcriptional programme. The factors influencing expression of this and other functional proteins should be relevant to the understanding and treatment of a range of neuromuscular disorders.
AuthorsStefan Gattenlöhner, Christiane Schneider, Claus Thamer, Rüdiger Klein, Wolfgang Roggendorf, Frank Gohlke, Caroline Niethammer, Stefanie Czub, Angela Vincent, Hans-Konrad Müller-Hermelink, Alexander Marx
JournalBrain : a journal of neurology (Brain) Vol. 125 Issue Pt 6 Pg. 1309-19 (Jun 2002) ISSN: 0006-8950 [Print] England
PMID12023319 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fetal Proteins
  • RNA, Messenger
  • Receptors, Cholinergic
Topics
  • Atrophy
  • Fetal Proteins (biosynthesis)
  • Humans
  • Muscle Fibers, Slow-Twitch (metabolism, pathology)
  • Neuromuscular Diseases (metabolism, pathology)
  • RNA, Messenger (biosynthesis)
  • Receptors, Cholinergic (biosynthesis, genetics)
  • Transcription, Genetic
  • Up-Regulation (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: